04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
The Federal Trade Commission (FTC) has announced its annual revisions to the thresholds under the Ha...
Read More >
The State of California has filed a notice of appeal of the district court’s decision granting a pr...
Read More >
Employers have paid about $7 billion in H-1B fees over the past 10 years. Now, a new fee is coming –...
Read More >
In Peters v. WCAB (Cintas Corp), No. 1835 C.D. 2017, the Commonwealth Court was tasked with deciding...
Read More >
The coronavirus has disrupted the economy and business activity, making it difficult or challenging ...
Read More >
On February 6, 2020 the U.S. Court of Appeals for the Third Circuit upheld a Philadelphia pay equity...
Read More >